Walter V. Klemp, Chief Executive Officer, 10% Owner at Moleculin Biotech, Inc. (MBRX), bought 12,000 shares at $0.81 ($10K) on 2017-05-11, disclosed to the SEC on 2017-05-12.
Open-market purchase of $10k MBRX by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| MBRX | BUY | 2022-11-28 | $58K | — | Filing → |
| MBRX | BUY | 2022-11-23 | $26K | — | Filing → |
| MBRX | BUY | 2022-11-18 | $191K | — | Filing → |